Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Free Tissue Flaps | 4 | 2022 | 59 | 2.220 |
Why?
|
| Perforator Flap | 2 | 2022 | 9 | 1.310 |
Why?
|
| Metacarpal Bones | 1 | 2022 | 1 | 0.790 |
Why?
|
| Soft Tissue Injuries | 1 | 2022 | 12 | 0.780 |
Why?
|
| Arteriovenous Malformations | 1 | 2022 | 47 | 0.760 |
Why?
|
| Wounds, Gunshot | 1 | 2022 | 147 | 0.730 |
Why?
|
| Mammaplasty | 2 | 2024 | 54 | 0.720 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 225 | 0.650 |
Why?
|
| Head and Neck Neoplasms | 3 | 2021 | 702 | 0.610 |
Why?
|
| Rhytidoplasty | 2 | 2015 | 8 | 0.570 |
Why?
|
| Postoperative Complications | 5 | 2022 | 3177 | 0.530 |
Why?
|
| Surgical Flaps | 3 | 2021 | 196 | 0.530 |
Why?
|
| Surgery, Plastic | 3 | 2022 | 105 | 0.470 |
Why?
|
| Sacrum | 1 | 2014 | 31 | 0.440 |
Why?
|
| Hematoma | 1 | 2014 | 94 | 0.420 |
Why?
|
| Mediastinal Diseases | 1 | 2011 | 15 | 0.370 |
Why?
|
| Breast Implants | 1 | 2011 | 31 | 0.370 |
Why?
|
| Lymphatic Diseases | 1 | 2011 | 31 | 0.370 |
Why?
|
| Licensure, Medical | 2 | 2022 | 22 | 0.360 |
Why?
|
| Arteries | 2 | 2022 | 230 | 0.350 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 447 | 0.310 |
Why?
|
| Blood Pressure | 1 | 2014 | 1420 | 0.290 |
Why?
|
| Tissue Expansion Devices | 1 | 2024 | 11 | 0.230 |
Why?
|
| Treatment Outcome | 4 | 2022 | 13073 | 0.210 |
Why?
|
| Safety-net Providers | 1 | 2024 | 62 | 0.210 |
Why?
|
| Clavicle | 1 | 2022 | 9 | 0.200 |
Why?
|
| Adult | 7 | 2024 | 31921 | 0.200 |
Why?
|
| Fibula | 1 | 2022 | 20 | 0.200 |
Why?
|
| Bone Transplantation | 1 | 2022 | 52 | 0.200 |
Why?
|
| Surgical Wound | 1 | 2022 | 23 | 0.190 |
Why?
|
| Facial Nerve Injuries | 1 | 2021 | 7 | 0.180 |
Why?
|
| Humans | 21 | 2024 | 134038 | 0.180 |
Why?
|
| Hand | 1 | 2022 | 107 | 0.180 |
Why?
|
| Private Practice | 1 | 2021 | 22 | 0.180 |
Why?
|
| Fee-for-Service Plans | 1 | 2021 | 19 | 0.180 |
Why?
|
| Face | 2 | 2021 | 189 | 0.180 |
Why?
|
| Hemangioma | 1 | 2022 | 97 | 0.180 |
Why?
|
| Raynaud Disease | 1 | 2020 | 4 | 0.180 |
Why?
|
| Thigh | 2 | 2021 | 52 | 0.170 |
Why?
|
| Internship and Residency | 2 | 2022 | 1250 | 0.170 |
Why?
|
| Job Application | 1 | 2020 | 21 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2022 | 188 | 0.170 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2021 | 66 | 0.170 |
Why?
|
| Skin Transplantation | 1 | 2020 | 59 | 0.160 |
Why?
|
| Middle Aged | 8 | 2024 | 29389 | 0.160 |
Why?
|
| Burns | 1 | 2020 | 100 | 0.160 |
Why?
|
| Educational Measurement | 1 | 2022 | 332 | 0.150 |
Why?
|
| Neck Dissection | 1 | 2018 | 31 | 0.150 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 154 | 0.150 |
Why?
|
| Reoperation | 2 | 2019 | 856 | 0.150 |
Why?
|
| Veins | 1 | 2018 | 108 | 0.140 |
Why?
|
| Skull | 1 | 2019 | 145 | 0.140 |
Why?
|
| Anatomic Landmarks | 1 | 2017 | 18 | 0.130 |
Why?
|
| Transplant Donor Site | 1 | 2017 | 6 | 0.130 |
Why?
|
| Female | 13 | 2024 | 71861 | 0.130 |
Why?
|
| Aged | 4 | 2018 | 21768 | 0.130 |
Why?
|
| Salvage Therapy | 1 | 2018 | 202 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 560 | 0.130 |
Why?
|
| Surgeons | 1 | 2021 | 284 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 2771 | 0.130 |
Why?
|
| Microsurgery | 1 | 2017 | 65 | 0.130 |
Why?
|
| Allografts | 1 | 2017 | 198 | 0.120 |
Why?
|
| Graft Survival | 1 | 2018 | 557 | 0.120 |
Why?
|
| Femoral Artery | 1 | 2017 | 192 | 0.120 |
Why?
|
| Superficial Musculoaponeurotic System | 1 | 2015 | 1 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17535 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 214 | 0.120 |
Why?
|
| Risk Factors | 3 | 2024 | 11179 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2022 | 1062 | 0.110 |
Why?
|
| Minnesota | 1 | 2014 | 181 | 0.110 |
Why?
|
| Molecular Probe Techniques | 2 | 2010 | 23 | 0.100 |
Why?
|
| Male | 6 | 2022 | 66063 | 0.100 |
Why?
|
| Rupture, Spontaneous | 1 | 2011 | 50 | 0.090 |
Why?
|
| Silicones | 1 | 2011 | 33 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 275 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2010 | 336 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1492 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 68 | 0.080 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 127 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 135 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2197 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 152 | 0.070 |
Why?
|
| Sirolimus | 1 | 2010 | 252 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2018 | 6601 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 271 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 232 | 0.070 |
Why?
|
| Aorta | 1 | 2009 | 564 | 0.060 |
Why?
|
| Hypertension | 1 | 2014 | 1396 | 0.060 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2010 | 447 | 0.060 |
Why?
|
| Acellular Dermis | 1 | 2024 | 7 | 0.060 |
Why?
|
| Child | 2 | 2022 | 25858 | 0.060 |
Why?
|
| Tissue Expansion | 1 | 2024 | 14 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 1 | 2008 | 559 | 0.060 |
Why?
|
| Forearm | 1 | 2022 | 47 | 0.050 |
Why?
|
| Chlorhexidine | 1 | 2022 | 49 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 4806 | 0.050 |
Why?
|
| Facial Nerve | 1 | 2021 | 26 | 0.050 |
Why?
|
| United States | 3 | 2022 | 11760 | 0.040 |
Why?
|
| Academic Performance | 1 | 2020 | 25 | 0.040 |
Why?
|
| Physician Executives | 1 | 2020 | 39 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 221 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 7214 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 138 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2022 | 376 | 0.040 |
Why?
|
| Patients | 1 | 2020 | 127 | 0.040 |
Why?
|
| Cicatrix | 1 | 2020 | 128 | 0.040 |
Why?
|
| Maxilla | 1 | 2019 | 39 | 0.040 |
Why?
|
| Head | 1 | 2019 | 113 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 1718 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2021 | 407 | 0.040 |
Why?
|
| Skin | 1 | 2020 | 545 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2020 | 510 | 0.030 |
Why?
|
| Young Adult | 2 | 2022 | 9928 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 1310 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 1740 | 0.030 |
Why?
|
| Disease Progression | 2 | 2010 | 2266 | 0.030 |
Why?
|
| Rats | 2 | 2010 | 3890 | 0.020 |
Why?
|
| Adolescent | 2 | 2022 | 20603 | 0.020 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2010 | 18 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3999 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2010 | 23 | 0.020 |
Why?
|
| Genes, APC | 1 | 2010 | 13 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2010 | 100 | 0.020 |
Why?
|
| Doxycycline | 1 | 2010 | 121 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 102 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2010 | 178 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 149 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 271 | 0.020 |
Why?
|
| Mice | 3 | 2010 | 19044 | 0.020 |
Why?
|
| Animals | 4 | 2010 | 36539 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 1088 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2010 | 456 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 746 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 592 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 780 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 827 | 0.020 |
Why?
|
| Infant | 1 | 2019 | 13220 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 3043 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1735 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 4013 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 1594 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3796 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6610 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 5084 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4934 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 6306 | 0.010 |
Why?
|